For more than 25 years, the Biosensors International Group (“Biosensors”) has been developing and marketing critical care catheter systems and related devices used during heart surgery and intensive care treatment. Continually striving to be at the forefront of product innovation, with a focus on improving patient outcomes today, we are driving the development of tomorrow’s next generation medical technology. The Biosensors International Group has operations worldwide and is headquartered in Singapore. The European headquarters are located in Morges (Switzerland).